Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 25:13:353-359.
doi: 10.2147/BCTT.S296242. eCollection 2021.

Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer

Francesca Savioli #  1 , Subodh Seth #  2 , Elizabeth Morrow  1 , Julie Doughty  3 , Sheila Stallard  3 , Andy Malyon  4 , Laszlo Romics  1   5
Affiliations

Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer

Francesca Savioli et al. Breast Cancer (Dove Med Press). .

Abstract

Introduction: Extreme Oncoplastic Breast Conservation Surgery (EOBCS) is offered in selected patients with multifocal or multicentric breast cancer (MFMC). Recent evidence has suggested that EOBCS may be a valuable resource for patients with MFMC who may avoid the risk associated with mastectomy in favour of the benefits of breast conservation without risking their oncological outcomes. Our study examined the practice of EOBCS in two regional breast units in Glasgow, United Kingdom.

Materials and methods: A prospectively collected database of 50 patients treated with EOBC in two breast units in Glasgow between 2007 and 2018 were evaluated, and clinical outcomes were observed.

Results: Fifty patients (median age 55) underwent EOBCS, of which 43 (86%) had invasive disease. Median tumour size was 55mm (50-90) and multifocal disease was identified in 22 (44%) patients. Nine patients (18%) were found to have positive margins and underwent a second procedure, with 6 (12%) proceeding to mastectomy. Five-year disease free survival rate was 91.5%, while cancer-specific survival was 95.7%.

Conclusion: EOBCS is oncologically safe in short-term follow-up. Large scale studies are required to confirm these preliminary results, in order to offer EOBCS as a valid option to patients with advanced or multifocal breast cancer.

Keywords: breast conservation therapy; extreme oncoplasty; multicentric breast cancer; multifocal breast cancer; therapeutic mammoplasty.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Silverstein MJ, Savalia N, Khan S, Ryan J. Extreme oncoplasty: breast conservation for patients who need mastectomy. Breast J. 2015;21(1):52–59. doi: 10.1111/tbj.12356 - DOI - PMC - PubMed
    1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–1232. doi: 10.1056/NEJMoa020989 - DOI - PubMed
    1. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast-cancer - long-term results of a randomized trial. Eur J Cancer. 1990;26(6):668–670. doi: 10.1016/0277-5379(90)90113-8 - DOI - PubMed
    1. Weber WP, Soysal SD, El-Tamer M, et al. First international consensus conference on standardization of oncoplastic breast conserving surgery. Breast Cancer Res Treat. 2017;165(1):139–149. doi: 10.1007/s10549-017-4314-5 - DOI - PubMed
    1. Masannat Y, Agrawal A, Maraqa L, et al. Multifocal and multicentric breast cancer, is it time to think again? AnnRoyal Coll Surg Engl. 2019;1–5. - PMC - PubMed

LinkOut - more resources